Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

So, there's this scientist, Arun Sanyal, M.D., who's the director of the VCU Stravitz-Sanyal Institute for Liver Disease and ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

A recent study reveals that semaglutide, a diabetes medication known for its weight-loss effects, shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), a common liver ...

In a new study, Ozempic - a drug sold to help with obesity and diabetes - is attributed to helping this disease.

Treating patients with semaglutide -- an anti-diabetic medication -- can halt and even reverse liver disease, according to a ...